Drug Trial Radar · NCT07641634
A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.
Last checked: Nov 19, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
44
Planned (sponsor's estimate)
Start
Oct 27, 2025
Primary completion
Jan 2027
Study completion Jan 2028
Sponsor
- Lead sponsor
- Prolium Bioscience, IncIndustry
- Sponsor type
- Industry
- First posted
- Jun 11, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A two-part study of PRO-203 administered subcutaneously in healthy adult volunteers and participants with Systemic Sclerosis (SSc).
Conditions
- Healthy Volunteers
- Systemic Sclerosis (SSc)
- Scleroderma, Systemic
- Scleroderma
Interventions
PRO-203Drug
PRO-203 administered as escalating single dose in healthy participants or as a single cycle in participants with systemic sclerosis.
PlaceboOther
Matching placebo comparator for Part 1 participants.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Adverse Events and Laboratory Abnormalities [Safety and Tolerability]Time frame: 13 weeks (Part 1) / 49 weeks (Part 2)
Locations
13 sites in 4 countries. Site status is shown where the registry gives one.
Nucleus Network
Melbourne, Victoria, Australia · Completed
Peking University Third Hospital
Beijing, China · Recruiting
Guangdong Provincial People's Hospital
Guangzhou, China · Recruiting
The Third Affiliated Hospital of Sun Yat-Sen University
Guangzhou, China · Recruiting
The First Affiliated Hospital of Zhengzhou University
Henan, China · Recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, China · Recruiting
The Second Affiliated Hospital of Nanchang University
Nanchang, China · Recruiting
Nanjing Drum Tower Hospital
Nanjing, China · Recruiting
Pingxiang People's Hospital
Pingxiang, China · Recruiting
Hospital Angeles Chihuahua
Chihuahua City, Mexico · Recruiting
Unidad Médica para la Salud Integral (UMSI)
San Nicolás de los Garza, Mexico · Recruiting
Kyung Hee University Hospital
Seoul, South Korea · Recruiting
Seoul National University Hospital
Seoul, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.